A US retrospective analysis showed significant seasonal and temporal variation in eosinophilic esophagitis-related emergency department visits.

Albumin infusion after orthotopic liver transplantation shows potential benefits, but consensus on optimal serum levels and protocols is lacking.

The FDA has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta.

Risk for pancreatitis was not elevated among users of tirzepatide relative to placebo, despite the presence of elevated pancreatic enzymes.

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for seniors and people with disabilities.

Efforts to limit access to mifepristone have received a boost from a federal judge who took the bench during Trump's first term.

Glucagon-like peptide 1 receptor agonist use is not associated with an increased risk for thyroid cancer over the short term.

The US FDA has warned Sanofi about deviations from cGMP for active pharmaceutical ingredients at their Genzyme manufacturing plant.

According to data from NHANES, there was no statistically significant correlation between increased serum iron levels and colorectal cancer risk.

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

Websites that sell compounded glucagon-like peptide-1 receptor agonists often partially inform or misinform consumers.

The US Department of Health and Human Services awards Moderna $590 million to continue developing a vaccine to protect against bird flu.